Weighing the cost of technology advances in medical devices
A New York Times op-ed entitled “In Cancer Care, Cost Matters,” described what may be one of the earliest accounts where doctors at Sloan-Kettering decided not to use a new cancer drug because of its extra cost when they were already using equally-effective drugs for their cancer treatments. The article piqued my interest. These days for any doctor who uses expensive technologies, it is easy to see where this evaluation …







![Stopping medication requires as much skill as starting it [PODCAST]](https://kevinmd.com/wp-content/uploads/The-Podcast-by-KevinMD-WideScreen-3000-px-4-190x100.jpg)
![Weaponizing food allergies in entertainment endangers lives [PODCAST]](https://kevinmd.com/wp-content/uploads/The-Podcast-by-KevinMD-WideScreen-3000-px-3-190x100.jpg)






![AI censorship threatens the lifeline of caregiver support [PODCAST]](https://kevinmd.com/wp-content/uploads/Design-2-190x100.jpg)